Search results
Gilead (GILD) Up as Twice-Yearly HIV Shot Prevents Infection
Zacks via Yahoo Finance· 2 days agoGilead's (GILD) twice-yearly, subcutaneous lenacapavir has demonstrated its potential as a new tool...
Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market...
Morningstar· 3 days agoFN Media Group News Commentary - The National Cancer Institute’s (NCI) funding of research projects is predicted to empower the Pancreatic Cancer Market to grow. Unlike traditional therapeutic ...
Industry groups back drugmakers' appeal in Zantac cancer lawsuits
Reuters· 3 days ago, opens new tab and other drugmakers to stop more than 70,000 lawsuits in Delaware over discontinued...
Will WHO’s new guidance spur hepatitis B immunisation?
Pharmaceutical Technology via Yahoo Finance· 3 days agoIn 2023, Global Data reported more than 50 companies are developing and utilising HBV peptides...
New Drug Provides Total Protection From H.I.V. in Trial of Young African Women
New York Times· 2 days agoStephanie Nolen has covered the global H.I.V. pandemic for more than 25 years. Researchers and...
Zentalis (ZNTL) Tanks After FDA Puts 3 Cancer Studies on Hold
Zacks via Yahoo Finance· 4 days agoZentalis' (ZNTL) three studies evaluating azenosertib for three different cancer indications face...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 3 days agoThe company also unveiled promising results in people age 18 to 59 years old with underlying...
Major drug companies cap asthma medication costs at $35 per month
WISN 12 Milwaukee· 2 days agoMajor pharmaceutical companies have agreed to cap out-of-pocket costs for some asthma patients at...
Gilead’s Twice-Yearly Shot Prevents HIV. Where the Stock Is Headed.
Barrons.com· 3 days agoIts older medicine, Truvada, is available as an inexpensive generic. ViiV Healthcare, an HIV-focused...
Merck's (MRK) 21-Valent Pneumococcal Jab Gets FDA Approval
Zacks via Yahoo Finance· 5 days agoMerck's (MRK) 21-valent pneumococcal conjugate vaccine, Capvaxive/V116, becomes the first PCV...